主页 > 医学文档 >
【drug-news】先灵葆雅一种快速神经肌肉阻滞逆转
The drug, called Bridion, was approved by the European Commission, following a recommendation last month by an advisory panel in support of the drug, also known as sugammadex.
Bridion was approved for reversal of neuromuscular block induced by rocuronium and vecuronium.
The medicine is awaiting approval in the United States. An advisory panel to the U.S. Food and Drug Administration in March voted that it was safe and effective.
In a late stage clinical trial, Bridion reversed the effects neuromuscular blockade within a few minutes -- nine to 12 times faster than the standard reversal agent, neostigmine, according to researchers. 本人已认领该文编译，24小时后若未提交译文，请其他战友自由认领。 纽约（路透通讯社）7月30日，欧洲监管当局已批准了一项突破性的新药，在星期二，药物制造商先灵葆雅公司说，与现有的其他药物相比，该药物能使病人迅速的摆脱麻痹。
这种药物叫做bridion ，上个月获得了欧洲委员会的批准，同时得到了一个支持该药的顾问小组的推荐，该药被认为与sugammadex同样出名。
bridion获得核准，具有逆转罗库溴铵及维库溴铵所诱导神经肌肉阻滞作用。
该药物正在等待美国核准。美国FDA的一个顾问组三月份投票表明该药是安全和有效的。
研究人员说，在临床试验的后期阶段， bridion在短时间内具有抗神经肌肉阻滞作用，作用比标准的拮抗组分新斯的明强9-12倍。 The drug, called Bridion, was approved by the European Commission, following a recommendation last month by an advisory panel in support of the drug, also known as sugammadex.
这种药物叫做bridion ，上个月获得了欧洲委员会的批准，同时得到了一个支持该药的顾问小组的推荐，该药被认为与sugammadex同样出名。
这句话翻译有问题，also known as sugammadex, 意思是该药品同样被称为sugammadex，bridion和sugammadex是同一个药品。 谢谢指正，网上查了一下，确实是同一个药品！ [标签:content1][标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-09-07 17:11
医学,生命科学网